USING AI TO IMPROVE QUALITY OF LIFE FOR DIABETIC PATIENTS

The world of startups is constantly moving and evolving. With the exponential growth of deep learning research and technologies in recent years, innovative new companies are often funded, acquired and transformed from startups to industry leaders extremely quickly. MedicSen is a startup focused on developing non-invasive treatments for diabetes, utilising connected devices, machine learning algorithms and a cloud platform to revolutionise diabetic patient's lives. By applying artificial intelligence and sensor tech, the algorithm can predict future glucose levels and risky events and, according to that, give the patient medical advice and instructions for the amount of insulin they need and at what time. Since we first met the MedicSen team at the 2016 Deep Learning in Healthcare Summit in London, their team has grown and their mission has evolved.